NCT02264808View on ClinicalTrials.gov

Developmental Outcomes

CompletedOBSERVATIONAL
Enrollment

21

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

December 3, 2018

Study Completion Date

December 3, 2018

Conditions
Hypoxic-Ischemic Encephalopathy
Interventions
OTHER

Developmental Outcomes

A Bayley-III developmental assessment will be performed study subjects at age 18-20 months

Trial Locations (1)

32610

University of Florida, Gainesville

All Listed Sponsors
collaborator

American Heart Association

OTHER

lead

University of Florida

OTHER

NCT02264808 - Developmental Outcomes | Biotech Hunter | Biotech Hunter